Skip to main content
Clinical Trials/NCT05156164
NCT05156164
Completed
Not Applicable

A Randomized Control Trial on the Effectiveness of Kinesio-taping in the Prevention of Painful Shoulder and in the Functional Recovery of the Hemiplegic Upper Limb in People With Stroke in Sub-acute Phase

I.R.C.C.S. Fondazione Santa Lucia1 site in 1 country30 target enrollmentJanuary 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke, Rehabilitation
Sponsor
I.R.C.C.S. Fondazione Santa Lucia
Enrollment
30
Locations
1
Primary Endpoint
To assess the change of Ritchie Articular Index
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This RCT aims to investigate the effectiveness of the early use of Kinesio-taping (KT) together with standard physiotherapy treatment, in the prevention of the shoulder pain of the hemiplegic upper limb following a cerebral stroke compared to conventional physiotherapy without KT treatment. As a secondary outcome, this RCT aims to investigate if KT could improve functional recovery and delay the onset of spasticity.

The study consists in two parallel groups of 15 participants each. The treatment and observation period will last 1 month.

Detailed Description

The following RCT single blind study will be performed in the Rehabilitative Operative Unit 4 of the I.R.C.C.S. Fondazione Santa Lucia in Rome, Italy. It aims to investigate the effectiveness of the early use of Kinesio-taping (KT) together with standard physiotherapy treatment, in the prevention of shoulder pain of the hemiplegic upper limb following a cerebral stroke, in the subacute phase. As a secondary outcome, a potential impact on functional recovery and on the onset of spasticity affecting the muscles of the upper limb will be evaluated. The early application of KT aims to prevent subluxation of the hemiplegic shoulder and therefore pain secondary to the prolonged mechanical stress of the capsulo-ligamentous and tendon structures, due to the weight of the limb in the antigravity position. A total of 30 patients will be enrolled by the investigators and randomly assigned to either the experimental group (EG) or the control group (CG). The EG, as part of the standard treatment, will be subject to a total of 4 applications of KT, each of which to be kept for 5 days a week followed by 2 days of rest, to safeguard skin integrity before a further application. The participants will be evaluated for eligibility at the admission after discharge from the Stroke Units of the local district area. The KT application will be carried out at an early stage, immediately after enrollment and possibly before the painful symptoms and subluxation are overt. The CG will undergo a KT application on the deltoid without support function, with the same frequency and duration as the EG (sham-application). The outcomes that will be evaluated are: the intensity of perceived pain (Ritchie Articular Index - RAI), the functionality of the upper limb (Fugl-Meyer Assessment - FMA-UE) and the presence of hypertonus in the muscles of the upper limb (modified Ashwort scale - MAS). The treatment lasted 4 weeks and the timing of data collection was organized as follows: T (0) - the initial assessment immediately after enrollment; T (1) - the intermediate evaluation performed before the fifth rehabilitation treatment; T (2) - the final evaluation performed at the end of the 8 treatments. Follow-up after discharge cannot currently be predicted due to hospital access restrictions due to the COVID pandemic.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
March 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
I.R.C.C.S. Fondazione Santa Lucia
Responsible Party
Principal Investigator
Principal Investigator

Stefano Brunelli

Principal investigator

I.R.C.C.S. Fondazione Santa Lucia

Eligibility Criteria

Inclusion Criteria

  • Patients with a first episode of ischemic or hemorrhagic stroke.
  • Hypotonia of the stabilizing muscles of the shoulder.
  • Enrollment within 1 month of stroke.

Exclusion Criteria

  • • Previous trauma or chronic tendinopathies of the shoulder musculature.
  • Skin problems such as wounds or hypersensitivity.
  • Severe psychiatric or cognitive deficits.
  • Anesthesia of the hemiplegic side.
  • Severe aphasia
  • Severe neglect

Outcomes

Primary Outcomes

To assess the change of Ritchie Articular Index

Time Frame: Initial assessment: after enrollment. Intermediate evaluation after 3 weeks, before the fifth treatment. Final evaluation after 5 weeks since enrollment

The Ritchie Articular Index (RAI) is an 4 point index for the numerical measurement of joint tenderness. It grades 0: no tenderness, 1: patient complained of pain, 2: patient complained of pain and winced, 3: patient complained of pain and winced and withdrew. 0 is the better outcome, 3 is the worse outcome. The shoulder joint pain will be assessed

Secondary Outcomes

  • To assess the change of Modified Ashwort Scale(Initial assessment: after enrollment. Intermediate evaluation after 3 weeks, before the fifth treatment. Final evaluation after 5 weeks since enrollment)
  • To assess the change of FUGL-MEYER ASSESSMENT UPPER EXTREMITY(Initial assessment: after enrollment. Intermediate evaluation after 3 weeks, before the fifth treatment. Final evaluation after 5 weeks since enrollment)

Study Sites (1)

Loading locations...

Similar Trials